Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shire Adderall XR Sales Suspended In Canada; FDA Stands By “Black Box”

Executive Summary

Differences between FDA and Health Canada's regulatory responses to adverse event reports for Adderall XR are likely to raise more questions about FDA's drug safety review process
Advertisement

Related Content

ADHD Class Warnings Could Be Strengthened Pending FDA Research
ADHD Class Warnings Could Be Strengthened Pending FDA Research
Shire Daytrana ADHD Patch To Launch In Early July With Some Class Labeling
Shire Daytrana ADHD Patch To Launch In Early July With Some Class Labeling
Abbott ADHD Drug Cylert Withdrawn But FDA Stops Short Of Immediate Recall
Abbott ADHD Drug Cylert Withdrawn But FDA Stops Short Of Immediate Recall
Adderall XR Reinstated In Canada Following Successful Appeal By Shire
Concerta Adverse Events Update On “Drug Watch” Web Site Advised By Cmte.
Shire Late-Stage Pipeline Is Focused On ADHD Market
Adderall XR adult indication

Topics

Advertisement
UsernamePublicRestriction

Register

PS045381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel